Migraine headache.
Morillo
Luis E
LE
Javeriana University, Faculty of Medicine, Department of Neurosciences, Neurology Unit and Clinical Epidemiology and Biostatistics Unit, Bogota, Colombia.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D004008:Diclofenac / Q000627:therapeutic use; D004878:Ergotamine / Q000627:therapeutic use; D006801:Humans; D007052:Ibuprofen / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy*; D009288:Naproxen / Q000627:therapeutic use; D023303:Oxazolidinones / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use; D018170:Sumatriptan / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D014363:Tryptamines; D062367:ortho-Aminobenzoates / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007211:Indoles; D023303:Oxazolidinones; D010880:Piperidines; D011759:Pyrrolidines; D012459:Salicylates; D014230:Triazoles; D014363:Tryptamines; D062367:ortho-Aminobenzoates; D004008:Diclofenac; C115647:eletriptan; C089750:zolmitriptan; C009500:tolfenamic acid; C093622:rizatriptan; D009288:Naproxen; D018170:Sumatriptan; D004878:Ergotamine; C106783:naratriptan; D007052:Ibuprofen